spacer
home > white papers > The Flexible Factory Concept: A flexible bioprocessing platform to meet the changing needs of biomanufacturing - GE Healthcare Life Sciences
WHITE PAPERS

GE Healthcare Life Sciences

phone + 1 800 526 3593
email cs-us@ge.com
web http://www.gelifesciences.com
email P.O. Box 643065 Pittsburgh, PA 15264-3065 United States of America

The Flexible Factory Concept: A flexible bioprocessing platform to meet the changing needs of biomanufacturing

For the past several years, the biopharma industry has been buffeted by dynamic market conditions that are rapidly reshaping manufacturing requirements. These factors include:

• The rise of small-market pharmaceuticals that do not require the production scale of the previous “blockbuster” drug model

• Increased titers and process productivity that generate more bulk-product within a much smaller manufacturing footprint

• The emergence of biosimilars and continued evolution of healthcare reform, which will increasingly pressure drug pricing and require greater cost discipline

• Greater competition and shorter patent protection timelines, which will further ratchet up time-to-market pressures

• Tighter capital markets that will create heightened scrutiny for all new investment projects
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

AirBridgeCargo expands its passive pharma solutions in partnership with SkyCell as it achieves the two-fold volume increase

AirBridgeCargo expands its passive pharma solutions in partnership with SkyCell as it achieves the two-fold volume increase AirBridgeCargo Airlines (ABC), one of the leaders in transportation of pharmaceutical products by air, and Zurich-based cold-chain ULD manufacturer SkyCell have sealed their partnership for the lease of all types of SkyCell containers to meet the demand for evolving volumes of passive pharmaceutical shipments, which reached around 3,500 tonnes for 1Q 2019 YOY and demonstrated a two-fold increase.
More info >>


White Papers

eSource: Reducing Site Workload for Better, Faster, Safer Clinical Trials

Clinical Ink

Unlike traditional electronic data capture (EDC), SureSource, Clinical Ink’s eSource platform, was designed from the beginning to minimize clinical trial complexity for site users. A Site Impact Survey provides scientific evidence regarding the impact of SureSource from 517 site users. Results confirm it significantly reduces workload, lessens queries, and improves data quality compared to paper and EDC. In this white paper, we quantitatively evaluate survey outcomes, provide qualitative feedback from survey respondents, and highlight the observed benefits of SureSource for transforming clinical research.
More info >>


Industry Events

Clinical Trials Europe | Partnerships, Outsourcing, Operations & Technology

27 August - 21 November 2019, Barcelona, Spain

On 19-21 November 2019, the clinical trial community's most influential stakeholders will be meeting in Barcelona to discuss the evolving landscape, honing in on what it takes to harness true value from partnerships, outsourcing, operations, technology and early clinical development, for a faster, more efficient route to market.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement